Parameterless Gene-Pool Optimal Mixing Evolutionary Algorithms.

When it comes to solving optimization problems with evolutionary algorithms (EAs) in a reliable and scalable manner, detecting and exploiting linkage information, that is, dependencies between variables, can be key. In this paper, we present the latest version of, and propose substantial enhancements to, the gene-pool optimal mixing evolutionary algorithm (GOMEA): an EA explicitly designed to estimate and exploit linkage information. We begin by performing a large-scale search over several GOMEA design choices to understand what matters most and obtain a generally best-performing version of the algorithm.

Towards artificial intelligence-based automated treatment planning in clinical practice: A prospective study of the first clinical experiences in high-dose-rate prostate brachytherapy.

Purpose: This prospective study evaluates our first clinical experiences with the novel ``BRachytherapy via artificial Intelligent GOMEA-Heuristic based Treatment planning'' (BRIGHT) applied to high-dose-rate prostate brachytherapy.

Methods And Materials: Between March 2020 and October 2021, 14 prostate cancer patients were treated in our center with a 15Gy HDR-brachytherapy boost. BRIGHT was used for bi-objective treatment plan optimization and selection of the most desirable plans from a coverage-sparing trade-off curve.

Achieving Highly Scalable Evolutionary Real-Valued Optimization by Exploiting Partial Evaluations.

It is known that to achieve efficient scalability of an Evolutionary Algorithm (EA), dependencies (also known as linkage) must be properly taken into account during variation. In a Gray-Box Optimization (GBO) setting, exploiting prior knowledge regarding these dependencies can greatly benefit optimization. We specifically consider the setting where partial evaluations are possible, meaning that the partial modification of a solution can be efficiently evaluated.

GPU-accelerated bi-objective treatment planning for prostate high-dose-rate brachytherapy.

Purpose: The purpose of this study is to improve upon a recently introduced bi-objective treatment planning method for prostate high-dose-rate (HDR) brachytherapy (BT), both in terms of resulting plan quality and runtime requirements, to the extent that its execution time is clinically acceptable.

Methods: Bi-objective treatment planning is done using a state-of-the-art multiobjective evolutionary algorithm, which produces a large number of potential treatment plans with different trade-offs between coverage of the target volumes and sparing organs at risk. A graphics processing unit (GPU) is used for large-scale parallelization of dose calculations and the calculation of the dose-volume (DV) indices of potential treatment plans.